Ahmad Javed, Garg Anuj, Mustafa Gulam, Mohammed Abdul Aleem, Ahmad Mohammad Zaki
Department of Pharmaceutics, College of Pharmacy, Najran University, Najran 11001, Saudi Arabia.
Institute of Pharmaceutical Research, GLA University, Mathura 281406, India.
Pharmaceutics. 2023 May 10;15(5):1448. doi: 10.3390/pharmaceutics15051448.
3D printing technology in medicine is gaining great attention from researchers since the FDA approved the first 3D-printed tablet (Spritam) on the market. This technique permits the fabrication of various types of dosage forms with different geometries and designs. Its feasibility in the design of different types of pharmaceutical dosage forms is very promising for making quick prototypes because it is flexible and does not require expensive equipment or molds. However, the development of multi-functional drug delivery systems, specifically as solid dosage forms loaded with nanopharmaceuticals, has received attention in recent years, although it is challenging for formulators to convert them into a successful solid dosage form. The combination of nanotechnology with the 3D printing technique in the field of medicine has provided a platform to overcome the challenges associated with the fabrication of nanomedicine-based solid dosage forms. Therefore, the major focus of the present manuscript is to review the recent research developments that involved the formulation design of nanomedicine-based solid dosage forms utilizing 3D printing technology. Utilization of 3D printing techniques in the field of nanopharmaceuticals achieved the successful transformation of liquid polymeric nanocapsules and liquid self-nanoemulsifying drug delivery systems (SNEDDS) to solid dosage forms such as tablets and suppositories easily with customized doses as per the needs of the individual patient (personalized medicine). Furthermore, the present review also highlights the utility of extrusion-based 3D printing techniques (Pressure-Assisted Microsyringe-PAM; Fused Deposition Modeling-FDM) to produce tablets and suppositories containing polymeric nanocapsule systems and SNEDDS for oral and rectal administration. The manuscript critically analyzes contemporary research related to the impact of various process parameters on the performance of 3D-printed solid dosage forms.
自美国食品药品监督管理局(FDA)批准首款3D打印片剂(Spritam)上市以来,医学领域的3D打印技术备受研究人员关注。这项技术能够制造出具有不同几何形状和设计的各类剂型。由于其灵活性且无需昂贵设备或模具,在设计不同类型药物剂型以制作快速原型方面,其可行性前景十分广阔。然而,近年来多功能药物递送系统的开发,特别是作为负载纳米药物的固体剂型,虽对制剂研发人员而言将其转化为成功的固体剂型颇具挑战,但仍受到了关注。纳米技术与医学领域3D打印技术的结合为克服与基于纳米药物的固体剂型制造相关的挑战提供了一个平台。因此,本手稿的主要重点是综述近期涉及利用3D打印技术设计基于纳米药物的固体剂型的研究进展。在纳米药物领域利用3D打印技术能够轻松地将液体聚合物纳米胶囊和液体自纳米乳化药物递送系统(SNEDDS)成功转化为片剂和栓剂等固体剂型,并可根据个体患者的需求定制剂量(个性化医疗)。此外,本综述还强调了基于挤出的3D打印技术(压力辅助微注射器 - PAM;熔融沉积建模 - FDM)在生产用于口服和直肠给药的含有聚合物纳米胶囊系统和SNEDDS的片剂和栓剂方面的实用性。该手稿批判性地分析了与各种工艺参数对3D打印固体剂型性能影响相关的当代研究。